---
title: "Minmetals New Energy released its performance for the first three quarters, with a net loss attributable to the parent company of 20.1 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262392079.md"
description: "According to the Zhitong Finance APP, Minmetals New Energy disclosed its third-quarter report for 2025. The company achieved revenue of 5.054 billion yuan in the first three quarters, a year-on-year increase of 33.96%; the net loss attributable to shareholders of the listed company was 20.1 million yuan; the net profit excluding non-recurring gains and losses was a loss of 55.14 million yuan; basic earnings per share were -0.01 yuan"
datetime: "2025-10-23T09:40:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262392079.md)
  - [en](https://longbridge.com/en/news/262392079.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262392079.md)
generator: "portal-rs"
---

# Minmetals New Energy released its performance for the first three quarters, with a net loss attributable to the parent company of 20.1 million yuan

According to the Zhitong Finance APP, Minmetals New Energy (688779.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 5.054 billion yuan in the first three quarters, a year-on-year increase of 33.96%; the net profit attributable to shareholders of the listed company was a loss of 20.1 million yuan; the net profit excluding non-recurring gains and losses was a loss of 55.14 million yuan; basic earnings per share were -0.01 yuan

### Related Stocks

- [688779.CN](https://longbridge.com/en/quote/688779.CN.md)

## Related News & Research

- [FDA Approves Tablet Form of Zanubrutinib for All Approved Indications](https://longbridge.com/en/news/298434766.md)
- [US Cocoa Futures (COCOA-F) Is down 2.04% on Sep 10: Here Is Why](https://longbridge.com/en/news/298575877.md)
- [Atrys Health Accelerates Growth and Slashes Debt in First Half of 2026](https://longbridge.com/en/news/298692631.md)
- [Randoncorp shifts Chapecó plant operations to Caxias do Sul and Araraquara sites](https://longbridge.com/en/news/298766201.md)
- [Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2](https://longbridge.com/en/news/298452346.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**